Optimal strategies for sequential validation of significant features from high-dimensional genomic data

Area of Science:

• Genomics
• Biostatistics
• Bioinformatics

Background:

• High-dimensional genomic studies identify features linked to phenotypic outcomes, such as differentially expressed genes and single-nucleotide polymorphisms (SNPs).
• These studies face challenges like high noise, low sample sizes, and the multiple testing problem, leading to potential false discoveries and missed true associations.
• Validating features across studies is difficult, as findings may not replicate due to differing study quality and separate multiple testing adjustments.

Purpose of the Study:

• To develop and evaluate a sequential validation strategy for improving feature identification in high-dimensional genomic studies.
• To determine the optimal ordering of studies within the sequential validation process based on study quality.
• To assess the impact of different multiple testing adjustment methods (Bonferroni-Holm, FDR) on the sequential validation strategy.

Main Methods:

• A sequential validation strategy was proposed, where significant features from one study are used as candidates in subsequent studies.
• Simulation studies were conducted to compare different ordering strategies for experimental studies, prioritizing those with higher quality (lower noise).
• The performance of the sequential validation strategy was analyzed using different multiple testing adjustment methods.

Main Results:

• Simulation studies demonstrated that ordering studies by quality in descending order is optimal for the sequential validation procedure.
• The choice of multiple testing adjustment method (Bonferroni-Holm vs. FDR) impacts the effectiveness of the strategy.
• Application to three large breast cancer gene expression studies confirmed the significant influence of the validation step order on real-world results.

Conclusions:

• A quality-ordered sequential validation strategy enhances the identification of critical genomic features across studies.
• This approach effectively addresses challenges in high-dimensional data analysis, including noise and multiple testing.
• The findings provide a robust framework for feature discovery and validation in complex genomic research, exemplified by breast cancer studies.